Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Anti-Inflammation in AD: PET Imaging Supplement

Authors not listed

University of California, Los Angeles · 2000

Abstract

The purpose of this study is to determine whether the anti-inflammatory drug celecoxib can delay the onset of Alzheimer Disease (AD) in people with Age Associated Memory Impairment (AAMI). This study will also evaluate genetic risk and brain structure as potential predictors of mental decline.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-11 MST

Cite this

APA
Anonymous. (2000). Anti-Inflammation in AD: PET Imaging Supplement. <em>University of California, Los Angeles</em>. https://clinicaltrials.gov/study/NCT00065169
Vancouver
Anonymous. Anti-Inflammation in AD: PET Imaging Supplement. University of California, Los Angeles. 2000.
BibTeX
@misc{anon2000AntiIn, title = {Anti-Inflammation in AD: PET Imaging Supplement}, author = {Anonymous}, journal = {University of California, Los Angeles}, year = {2000}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings